TAMARA RIVENBURGH-CASILLAS: Open Payments
NPI 1134102965 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,090 in 98 payments from 15 companies in 2025. Trend: 2023 $1,771 · 2024 $2,444 · 2025 $2,090
Food & beverage: $1,982Education: $109
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $305 |
| Arcutis Biotherapeutics, Inc. | 13 | $295 |
| Incyte Corporation | 8 | $249 |
| GENZYME CORPORATION | 6 | $215 |
| Janssen Biotech, Inc. | 6 | $197 |
| ABBVIE INC. | 21 | $174 |
| UCB, Inc. | 6 | $118 |
| Amgen Inc. | 5 | $95 |
| Regeneron Healthcare Solutions, Inc. | 3 | $87 |
| PFIZER INC. | 5 | $86 |
Products named: Zoryve, OPZELURA, DUPIXENT, TREMFYA, SKYRIZI, Bimzelx, COSENTYX, OTEZLA.
Industry payments across AZ — which companies pay providers there.
